India’s AYUSH Exports Reach New Heights in 2024, Driven by Global Demand for Traditional Medicine

India’s AYUSH (Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy) exports surged to $587 million in the first quarter of 2024, according to the Ministry of AYUSH. This growth reflects increasing global interest in traditional medicine, with the European Union and the United States emerging as key markets. The data, released in April 2024, underscores the sector’s role in India’s healthcare and economic strategy.

What is the AYUSH Sector and Why Is It Growing?

The AYUSH sector encompasses six traditional systems of medicine, with Ayurveda and Yoga being the most recognized globally. According to the World Health Organization (WHO), 80% of Indians rely on traditional medicine for primary healthcare, and demand is rising internationally. In 2023, the global market for Ayurvedic products reached $4.2 billion, with India contributing 60% of exports, as reported by the Indian Council of Forestry Research and Education (ICFRE).

“The AYUSH sector is not just about wellness; it’s a strategic pillar of India’s health diplomacy,” said Dr. Anurag Agrawal, director of the Centre for Policy Research. “Countries are increasingly seeking sustainable, holistic healthcare solutions, and India is positioned to lead.”

Where Are India’s AYUSH Exports Going?

The European Union remains India’s largest export destination for AYUSH products, accounting for 35% of total exports in 2024. The U.S. follows with 25%, driven by demand for herbal supplements and yoga-related wellness products. Other key markets include the United Arab Emirates (15%), Singapore (10%), and Australia (8%), according to the Department of Commerce.

“Europe’s regulatory framework for herbal medicines has created opportunities for Indian manufacturers,” noted Rajiv Sharma, a trade analyst at the Federation of Indian Export Organizations (FIEO). “Certifications like the European Medicines Agency (EMA) compliance are now critical for market access.”

How Is the Indian Government Supporting AYUSH Exports?

The Ministry of AYUSH has launched initiatives to standardize products and improve export infrastructure. A $50 million fund was allocated in 2023 to support quality control labs and digital marketing for AYUSH brands. Additionally, the government has signed agreements with the European Union and the Association of Southeast Asian Nations (ASEAN) to streamline trade barriers.

“We are focusing on building a robust supply chain,” said Union Minister for AYUSH, Sarbananda Sonowal. “This includes training exporters on international standards and promoting AYUSH through global health summits.”

What Challenges Does the AYUSH Sector Face?

Despite growth, the sector faces hurdles such as inconsistent quality control and regulatory discrepancies between countries. In 2023, the U.S. Food and Drug Administration (FDA) issued warnings about adulterated herbal supplements from India, prompting stricter import checks. Experts emphasize the need for greater transparency and adherence to international standards.

“Quality assurance is non-negotiable,” said Dr. Meera Kapoor, a pharmacologist at the All India Institute of Medical Sciences (AIIMS). “Without trust, the global market will remain inaccessible.”

Why Does This Matter for Global Health and Trade?

The expansion of AYUSH exports aligns with global trends toward integrative medicine. In 2022, the WHO endorsed traditional medicine in its global health strategy, creating new avenues for collaboration. For India, the sector represents a $10 billion opportunity by 2025, according to a report by the Confederation of Indian Industry (CII).

“This is not just an economic win—it’s a cultural one,” said Dr. Singh, a board-certified internal medicine physician. “Traditional medicine bridges ancient knowledge with modern science, offering solutions for chronic diseases and preventive care.”

What’s Next for AYUSH Exports?

Industry leaders anticipate further growth as countries adopt hybrid healthcare models. The government plans to host the Global Ayurveda Summit in 2025, aiming to attract $2 billion in foreign investment. However, success will depend on addressing quality concerns and expanding research into the efficacy of AYUSH treatments.

“The future of AYUSH lies in innovation and evidence-based practices,” said Dr. Agrawal. “If India can balance tradition with scientific rigor, the global market will take notice.”